Research and Markets: Monoclonal Antibodies Market to 2017 - Monoclonal ... Benzinga (press release) The first FDA-approved therapeutic monoclonal antibody was a murine IgG2a CD3 specific transplant rejection drug, OKT3 (also called muromonab) in 1986. This drug found use in solid organ transplant recipients who became steroid resistant. |
